Human coagulation factor Ⅷ (Shanghai Xinxing)

人凝血因子Ⅷ（上海新兴医药）

Report date: 2022/03/09 14:43:52

Base Information

Drug NameHuman coagulation factor Ⅷ (Shanghai Xinxing)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor
Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsBlood coagulation pathway activation
TargetsCoagulation factor X
Therapy Area/IndicationsHemorrhagic DisordersHemophilia A
Global Approved IndicationsHemorrhagic DisordersHemophilia A
Approved Indications in ChinaHemorrhagic DisordersHemophilia A
Original Approved Country/TerritoryMainland China
Original Approved Date2015/07/27
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShanghai Xinxing Medicine Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Xinxing Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsHemorrhagic DisordersHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG